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Formation of the placenta is a crucial step in mammalian pregnancy. Apart from its function in ensuring
an optimal supply of nutrients and oxygen to the fetus, the placenta is also the interface at which allo-
recognition of invading trophoblast cells by the maternal immune system can potentially occur. We
summarise here the “state of the art” on how variability of immune system genes that code for major
histocompatibility complex (MHC) molecules and natural killer receptors (NKR) may impact on human
placentation. MHC and NKR are the most polymorphic human genes. Our recent reports point out that
speciﬁc combinations of fetal MHC and maternal NKR genes in humans correlate with the risk of pre-
eclampsia, recurrent miscarriage (RM) and fetal growth restriction (FGR). Research in this ﬁeld is still
at an early stage and future studies in mouse and humans will be needed before the results can be
translated to clinical applications. We discuss our recent work, as well as the opportunities offered by
mouse genetics, to understand the cellular and molecular mechanisms underlying immune interactions
at the maternal-fetal interface.
 2011 Elsevier Ltd. Open access under CC BY license.1. Introduction
Uterine natural killer (uNK) cells are the mainmaternal immune
cells present in decidualised endometrium prior to and during the
establishment of the placenta in species with invasive haemocho-
rial placentation (including humans and mice) [1]. NK cells are part
of the lymphoid lineage and like T and B lymphocytes can be
divided in several subpopulations [2]. The NK cells present in the
uterus are phenotypically and functionally unlike those present in
the systemic circulation [3,4]. Their exact functions in pregnancy
are unknown, but available evidence points to a role in regulating
the complex process of placentation. In particular, they are thought
to be involved in co-ordinating access of the placental trophoblast
cells to the uterine arteries. Trophoblast transformation of the
arteries results in high conductance vessels, ensuring an adequate
supply of oxygen and nutrients to the feto-placental unit in both
human and mouse [5e8].
Many of the genes selected during evolution to regulate repro-
duction are invariable. However, reproduction is the only naturalnd Gynaecology, University of
al, Robinson Way, Cambridge
215327.
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BY license.situation in vertebrates where two genetically different individuals
coexist. Therefore, the intrinsic variability of immune system genes
may well be one of the key selective pressures shaping the evolu-
tion of highly invasive haemochorial placentation. Lymphocytes
have a variety of receptors capable of discerning ligands present on
unhealthy cells or on those from another individual and indeed,
uNK cells do have an array of receptors capable of binding fetal
trophoblast ligands [9e11]. One important set of ligands for NK
cells are MHC class I molecules, some of which are expressed by
invasive trophoblast [12]. MHC and NKR are both highly poly-
morphic gene systems and indeed they are unique in their extreme
variability [13,14].
We have established that certain combinations of maternal NKR
and fetal MHC genotypes are risk factors for common disorders of
pregnancy in humans [15e18]. Understanding how ‘good’ or ‘bad’
NKR/MHC combinations translate into different NK cell functions
and subsequently affect trophoblast invasion and arterial blood ﬂow
is now a major challenge. The human maternal-fetal interface is
inaccessible in early pregnancy and it is impossible to determine at
this stage the pregnancies that will result in a poor outcome. To
surmount these difﬁculties in human pregnancy research, we have
begun to explore the similarities and differences between human
and mice NKR and potential trophoblast ligands with the aim of
developing mouse models that will elucidate how NK celletropho-
blast interactions contribute to placentation.
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The invasion of human extravillous trophoblast (EVT) into
decidua with transformation of the spiral arteries is well docu-
mented [1,8]. This process is a critical determinant of reproductive
outcome with defective invasion leading to major clinical problems
in pregnancy, including pre-eclampsia [19], FGR [20,21] and RM
[22,23]. The decidua basalis where the placenta implants is the
main tissue site where cells from two individuals intermingle.
Because the placental cells are semi-allogeneic, a reasonable
hypothesis is that the maternal uterine immune cells regulate
trophoblast behaviour. NK cells are present in great abundance at
the site of placentation in both humans and mice [1] (Fig. 1). The
transformation of the uterine mucosa from endometrium to
decidua is characterised by the appearance of large numbers of
distinctive NK cells not found elsewhere in the body [24]. Although
they may inﬂuence other uterine leukocytes [25], affect glandular
functions [26], modify blood ﬂow directly by acting on spiral
arteries [5] or regulate trophoblast invasion [6], their precise
functions are unknown.
Mice lacking uNK are fertile but display inadequate uterine
vascular remodelling during pregnancy, poor decidualisation [7]
and low fetal weight [27,28], highlighting the importance of NK
cells in placentation. Despite the differences between mouse and
humans in the anatomical details of placentation, length ofFig. 1. Immunohistochemistry of midsagittal sections of a mouse implantation site at ge
accumulate in the decida basalis (DB). The red arrow points to a DBAþ uNK cell; B) The
spongiotrophoblast (ST), invasive giant cells (GC, light blue arrow) and labirinth (L). Fetal
associated with maternal uterine vessels (UV) and may participate in their remodelling; E)
arrows) within endothelial cells (EC) and several DBAþ uNK cells in the media (blue arrowgestation, time of decidualisation and location of uNK cells, there
are also remarkable similarities (Table 1) [1,3,4,7,11,18,29e33].
Notably, NK cells in both species are temporally and spatially
associated with trophoblast inﬁltration into decidua and they are
particularly prominent around the spiral arteries [1,34]. In both
species, there is a decline in these granulated NK cells from mid-
gestation onwards so they are relatively sparse at term [35,36].
Our recent ﬁndings also show that like humans, mouse uNK cells
express multiple NKR with a repertoire different from peripheral
NK cells [32]. Have the NKR on these NK cells become specialised to
recognise and respond to ligands on trophoblast cells?
3. NK cell receptors
NK cell function is controlled by many activating and inhibitory
receptors. Structurally, NKR are of two types: Immunoglobulin-like
(Ig) receptors (human, killer immunoglobulin-like receptor, KIR) or
C-type lectin-like receptors (human and mouse CD94/NKG2 and
mouse Ly49). KIR genes are clustered in the leukocyte receptor
complex (LRC) along with other NKR genes (e.g. LILR, LAIR, NCR1)
and genes biologically relevant to pregnancy (e.g. PSG, CGB, FCRGT)
on human chromosome 19. CD94/NKG2 genes together with NKG2D
cluster in the NK gene complex (NKC) on human chromosome 12
and mouse chromosome 6, which also includes Ly49 genes (Fig. 2)
[18,37e43].stational day 8.5. A) uNK cells, stained brown by Dolichos Biﬂorus Agglutinin (DBA)
adjacent section was stained with cytokeratin to identify trophoblast cells, including
vessels (FV) with nucleated red cells are also visible; CeD) The DBAþ uNK cells are
A higher magniﬁcation of the ﬁeld in C) shows two intravascular DBAþ uNK cells (red
); F) DBAþ uNK cells at this stage are large and with prominent granules.
Table 1
Comparison of the maternal-fetal interface in humans and mice.
Feature Human Mouse
Similarities in placenta type Discoidal, chorio-allantoic [29] Discoidal, chorio-allantoic [29]
Haemochorial placentation Yes Yes
Decidualised endometrium Yes, during each menstrual cycle [29] Yes, triggered by implantation [29]
Disproportionate feto-placental growth Fetal growth disproportionally higher compared
with placental growth in late gestation [29]
Fetal growth disproportionally higher compared with
placental growth in late gestation [29]
Syncytial transport and barrier trophoblast Chorionic villi with syncytiotrophoblast barrier
formed by cell fusion. Diploid nuclear DNA content [30].
Labyrinth with syncytiotrophoblast barrier formed by
cell fusion. Diploid nuclear DNA content [30]
Invasive trophoblast Non-proliferative, mononuclear polyploid
cytotrophoblast [30]. Invasion of decidua basalis
and inner third of the myometrium and differentiation
into trophoblast giant cells. EVT face maternal
immune system [29].
Non-proliferative, mononuclear polyploid trophoblast
with giant cells [30]. Invasion of decidua basalis.
Trophoblast giant cells face maternal immune
system [29]
Selective MHC class I expression by trophoblast HLA-C, HLA-G and HLA-E; no HLA-A or HLA-B [12] H2-K; no H2-D or Qa1 (in C57BL/6 mice [31])
Unique uNK phenotype CD69þ CD117þ/-KLRG1high CD56superbrightCD9þ
CD94bright [3, 4]
CD69þ CD117þ KLRG1high NK1.1-DX5- [32]a
Activating NKR on uNK cells NKG2D, NKp46, KIR2DS1 [6, 18] NKG2D, NKp46, Ly49H, CD16 [32]
Inhibitory NKR on uNK cells KLRG1, KIR2DL1/2/3, NKG2A [3, 6] KLRG1, Ly49A, Ly49C, Ly49G2 [31, 32]
Vascular changes concomitant with uNK
inﬁltration of uterus
uNK cells accumulate at site of placentation during the
ﬁrst trimester concentrating around spiral arteries [1]
High degree of uNK cell inﬁltration at gestational day
9.5 [30] around the spiral artery [7]
Highly polymorphic receptor/ligand systems KIR on uNK/HLA-C on EVT [18] Ly49s on uNK/H2-K on trophoblast giant cells [31, 32]
Expression of paternal MHC Yes [18] Yes [31]
Impact of paternal MHC on reproductive
success
Combination of maternal KIR-AA and fetal HLA-C2
genotypes increases the risk for pre-eclampsia,
FGR and RM [15,17,18]
Antigenic disparity between parental H2-linked genes
affects transformation of the uterine
vasculature, as well as fetal growth and placental
efﬁciency [31]
a A different immunophenotype of decidual NK cells in C57BL/6 mice was reported by Mallidi et al., although the cells analysed in this study were mostly DBA- NK1.1þ [31].
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lymphocytes, the genes coding for NKR do not undergo somatic
recombination but are instead germ-line encoded [44]. This means
they are subject to natural selection. In the case of human KIR
genes, balancing selection preserves a high degree of poly-
morphism in the population, suggesting that no single KIR haplo-
type confers an absolute ﬁtness advantage to an individual [45].
Indeed, recent comparison between human and simian KIR genes
shows they are rapidly evolving [46]. KIR surface expression is
stochastic on individual NK cells [47] and the variegated nature of
expression results in many NK cell subsets.
Although the human KIR and mouse Ly49 families are struc-
turally distinct, the intracellular signalling pathways of these
receptors are largely conserved [44,48]. Moreover, they represent
a remarkable example of convergent evolution as they mediate the
same functions in the two species; they bind MHC class I molecules
and regulate NK cell function [37]. Both KIR and Ly49 gene families
are multigenic and polymorphic with different haplotypes having
variable gene content including both inhibitory and activating
receptors. In addition, both variability in KIR and Ly49 receptors
and their MHC ligands determines the outcome of bone marrow
transplantation (BMT) further illustrating their homologous func-
tions [49,50]. In mice, the phenomenon of hybrid resistance has
been invaluable in illuminating translational research in BMT [51].
Transplantation is, however, an artiﬁcial context and the only
physiological situation in mammals where NK allo-recognition can
occur is during pregnancy. Can murine models therefore unravel
the secrets of natural allo-recognition occurring at the maternal-
fetal interface in utero?4. NKR on uterine NK cells and trophoblast MHC ligands
Uterine NK cells do express KIR in humans [10,11] and Ly49 in
mice [32] as well as a variety of other NKR [4,52,53]. Importantly,
the expression of NKR differs in human uNK cells compared to
peripheral NK cells: uNK cells are deﬁned as CD56superbright
CD16 but unlike their CD56bright peripheral counterparts, they
express KIR, NKG2C and NKG2E, as well as CD69, CD117, KLRG1
and CD94 [3,4]. Given the key roles of MHC class I molecules in
ontogeny and function of NK cells, MHC expression on tropho-
blast cells is obviously important to deﬁne. In humans, the
repertoire of trophoblast HLA class I expression is unique and can
be summarised [12]:
i) No expression of HLA-A or HLA-Bmolecules, which are highly
polymorphic and function mainly as T cell ligands.
ii) Expression of oligomorphic non-classical HLA-G and HLA-E
molecules, which are ligands for LILR molecules mainly
expressed by myeloid cells and the NKR, CD94/NKG2
respectively [54].
iii) Expression of polymorphic classical HLA-C molecules that are
the only HLA providing variability and thus may act as a fetal
allogeneic ligand depending on the paternal HLA-C.
iv) EVT is the predominant site of HLA-C expression in decidua
and paternal HLA-C allotypes are expressed [18].
In collaboration with Myriam Hemberger, we have recently
characterised the expression of trophoblast MHC in the C57BL/6
mouse and found [31]:
Fig. 2. Comparative Genomics of NKC and LRC in human and mouse. A schematic map of the NKC and the LRC encompassing genes encoding for lectin-like and Ig-like NKR and emphasizes the functional homology of human KIR [18]
and mouse Ly49 [38] genes that arose by convergent evolution [37]. Two typical human KIR haplotypes (A and B) and mouse Ly49 haplotypes (BALB/c and C57BL/6) are shown. The MHC class I ligands for the cognate receptors are also
depicted for both human and mouse. For clarity, only one MHC class I molecules is indicated for each of the Ly49 receptors, however individual Ly49 receptors can bind multiple MHC class I molecules. For example Ly49C can bind H2-Kb
and H2-Kd [39]. The ﬁgure is not drawn to scale and not all genes that map to the NKC and the LRC are indicated. Additional information can be found in references [40e43].
F.Colucci
et
al./
Placenta
32
(2011)
539
e
545
542
F. Colucci et al. / Placenta 32 (2011) 539e545 543i) Only one classical MHC class I, H2-K, but not H2-D is
expressed.
ii) No non-classical MHC is expressed.
iii) Paternally-inherited H2-K is expressed by trophoblast
invading into maternal decidua.
The H2-K molecule was expressed on the surface of
trophoblast stem cells (TS) analysed by ﬂow cytometry and by
immuno-precipitation of surface proteins. This was conﬁrmed,
and intracytoplasmic staining was also seen, when implantation
sites at gestation day 8.5 and TS cells were stained for
co-localisation of H2-K and cytokeratin or Cdh3 in immunoﬂu-
orescence microscopy [31].
The parallels, therefore, are that in both humans and mice,
MHC expression is selective and differs from other somatic cells.
In addition, crucially, we have found paternally inherited MHC
antigens are expressed at the maternal-fetal interface in both
species so that NK-mediated allo-recognition can potentially
occur [18,31].
5. HLA-C and KIR
The great diversity of both NKR and MHC genes has been
explained by their key roles in the effectiveness of immune
responses to pathogens illustrated by a variety of human and
mouse studies [55,56]. Our ﬁndings now suggest that these
immune system genes also affect reproductive success [18,31].
We have a range of evidence to show that there is an important
role for NKR andMHC genes in human pregnancy. Because HLA-C is
the only trophoblast HLA class I molecule showing any appreciable
polymorphism, we investigated expression in uNK cells of those
KIR that are devoted to binding HLA-C [11]. We found that:
i) Uterine NK cells express elevated levels of the KIR known to
bind HLA-C (KIR2DL1/S1 and KIR2DL2/L3).
ii) HLA-C tetramers bind uNK cells more than peripheral NK
cells.
iii) KIR2DL1 and KIR2DS1-Fc fusion proteins bind speciﬁcally to
surface HLA-C molecules on normal trophoblast [18].
iv) Other groups have found that uNK cell function is altered
following ligation of KIR [6].
Given the difﬁculty in determining exactly how uNK cells might
function in different pregnancies where maternal KIR and fetal
HLA-C are both variable, we have used a genetic approach to show
how polymorphism of KIR and HLA-C genes might affect maternal-
fetal interactions [15e17]. Genetic epidemiological studies linking
certain combinations of human NKR and MHC have driven the
biological experiments needed to determine mechanisms of
immunity to viruses and we predict a similar development in the
ﬁeld of reproduction. HLA-C ligands for KIR are divided into two
groups based on a dimorphism at position 80 of the a1 domain of
HLA-C alleles: HLA-C1 (Asn80) binds inhibitory KIR2DL2/3 and HLA-
C2 (Lys80) binds inhibitory KIR2DL1 as well as activating KIR2DS1.
The simplest way to analyse KIR diversity is to consider all KIR
haplotypes as either A or B. KIR A haplotypes are simple with 7
genes including only one activating KIR (2DS4) that is frequently
disabled. KIR B haplotypes are more variable (<12 genes); these
extra genes are mostly activating [45].
We have found that in 3 different pregnancy disorders, all
characterised by defective placentation (pre-eclampsia, FGR and
RM), the pregnancies most at risk are those where the mother has
a KIR AA genotype and there is a HLA-C2 group in the fetus [15e17].
Furthermore, when the frequency of individual KIR B haplotypes
genes was compared between control and affected women, thegenes most reduced in frequency in affected women were at the
telomeric end of the B haplotype [18]. This is where the activating
KIR for HLA-C2 allotypes, KIR2DS1, is located. An additional
preliminary ﬁnding was that fetal HLA-C2 is a risk factor in KIR AA
women when it is paternally rather than maternally derived [18].
This risk can bemodiﬁed by thematernal C1 or C2 status in keeping
with the ‘rheostat model’, according to which NK cell responsive-
ness is gradually modulated by inhibitory MHC-NKR interactions
during education of the NK receptor repertoire [57]. This suggests
that maternal NK cells are educated during their development so
that they are calibrated to the levels of maternal HLA-C. Thus, uNK
responses to the fetus might differ depending on the dose of fetal
HLA-C2 relative to that of the mother’s HLA-C2 because of the
exquisite sensitivity of NK cells to levels of self-MHC. In other
words, maternal C2 genes could modify the risk conferred by fetal
C2 and in keeping with this we ﬁnd that the KIR AAwomen most at
risk are those who are HLA C1/C1 haplotype carriers confronted by
fetal C2 [18].
6. Mouse
The studies in humans reveal the great complexity of NKR-MHC
interactions and the need to consider three variables: maternal
HLA-C, fetal HLA-C and maternal KIR. Indeed, we have not yet
explored the diversity further and considered the contribution of
individual alleles of both HLA-C and KIR (particularly 2DL1, 2DL2,
2DL3 and 2DS4 that can all bind subsets of HLA-C allotypes [58,59]).
Furthermore, the heterogenous nature of these pregnancy disor-
ders and the lack of any easy clear clinical diagnosis of defective
placentation makes further progress challenging.
We believe that mouse models can be used to dissect this
complexity and determine how individual NKR/MHC combinations
inﬂuence placentation. Themouse has proved crucial in unravelling
how NK cells function in infections [60], BMT [50] and cancer [61].
There are also murine studies (many from Anne Croy’s pioneering
work) on the role of uNK cells [62]. Most of the previous work has
been conducted in syngeneic mice, however, thus excluding the
impact of NKR and MHC variability on placentation.
Recently, we have used both MHC-allogeneic and -congenic
mice and shown that paternal MHC affects reproductive outcome
[31]. We have also developed robust outcomes of placentation and
feto-placental growth, including direct measurements of tropho-
blast invasion and vascular remodelling. Parameters such as litter
size and fetal weight directly determine reproductive success.
Evaluation of spiral artery diameter, depth of EVT invasion and
placental weight provides insights into indirect effects of indi-
vidual NKR/MHC combinations. Furthermore, the relatively short
life span of micemakes them a suitablemodel for studies focussing
on long-term effects of impaired placentation. For example,
insufﬁcient supply of nutrients during fetal development may not
have obvious direct effects for the newborn and indeed mice
lacking NK cells do produce normal litter sizes. However birth
weights are smaller in some NK-deﬁcient strains, such as Irf1/
[27] and Il15/ mice [28] and thus insufﬁcient nutrient supply
during fetal life could prove disadvantageous later in life as it has
been shown for the increased risk of hypertension and coronary
heart disease in humans [63].
These ﬁndings and experimental protocols will allow future
experiments where genetically modiﬁed mice, for example con-
genic for NKR, lacking H2-K or expressing known NK ligands as
transgenes can be used. Additional questions relating to uNK cell
memory and uNK cell education by maternal and fetal MHC can
also be addressed in a systematic way. The phenomenon of NK
cell memory [64], where NK cells respond more readily to the
same insult on secondary encounter has obvious relevance to
F. Colucci et al. / Placenta 32 (2011) 539e545544human pregnancy - the risk of pre-eclampsia is reduced after
a successful ﬁrst pregnancy but this effect is lost after long
interbirth intervals [65].
7. Future directions
Although our initial genetic studies have revealed that particular
combinations of NKR KIR and MHC HLA-C genotypes are associated
with an increased risk of pregnancy disorders, much further work
at both genetic and functional levels is required before these
ﬁndings can be translated to the clinic. Firstly, becausewe have only
genotyped British people of European descent to date, similar
genetic studies must be performed in other populations. Because of
the high incidence of pre-eclampsia in Africans, this will be
a particularly informative population to study.
Furthermore, we have only performed basic KIR and HLA gen-
otyping and not considered allelic variation. In the context of
hepatitis C virus infections, where HLA-C1/C1 haplotype carriers
homozygous for KIR2DL3 have a higher probability of resolution
[66], certain HLA-C alleles are now emerging as particularly
beneﬁcial [67]. Those KIR that can potentially bind HLA-C2 allo-
types (2DL1, 2DL2, 2DS4 and 2DS1) also show some allelic varia-
tion and this is likely to be functionally important. Future
prospective studies with large numbers of well-characterised
pregnancies and information on uterine artery blood ﬂow are
needed before any deﬁnitive conclusions can be reached about
‘good’ or ‘bad’ KIR/HLA-C combinations in humans. These will need
to be supported by functional assays using uNK cells isolated from
ﬁrst trimester decidua and experiments using mouse models with
deﬁned NKR/MHC combinations. Nevertheless, the ﬁndings to date
do indicate that immune system genes are likely to be important in
reproductive success. Interestingly, a powerful and diverse
immune system comes with a price for the individual [68] and
a trade-off between its function and reproductive success has been
suggested in humans [69] and described in other species such as
Soay sheep [70].
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